Literature DB >> 14593164

Future brightening for depression treatments.

Constance Holden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593164     DOI: 10.1126/science.302.5646.810

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  5 in total

1.  'Me-Too' Innovation in Pharmaceutical Markets.

Authors:  Anupam B Jena; John E Calfee; Edward C Mansley; Tomas J Philipson
Journal:  Forum Health Econ Policy       Date:  2009-11-04

Review 2.  Chronobiological Therapy for Mood Disorders.

Authors:  Sara Dallaspezia; Masahiro Suzuki; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-12       Impact factor: 5.285

Review 3.  Marine indole alkaloids: potential new drug leads for the control of depression and anxiety.

Authors:  Anna J Kochanowska-Karamyan; Mark T Hamann
Journal:  Chem Rev       Date:  2010-08-11       Impact factor: 60.622

4.  Bcl-2 immunoreactive neurons are differentially distributed in subregions of the amygdala and hippocampus of the adult macaque.

Authors:  J L Fudge
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

5.  Running wheel activity is sensitive to acute treatment with selective inhibitors for either serotonin or norepinephrine reuptake.

Authors:  Martin Weber; Sonja Talmon; Ilka Schulze; Christine Boeddinghaus; Gerhard Gross; Hans Schoemaker; Karsten M Wicke
Journal:  Psychopharmacology (Berl)       Date:  2008-12-23       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.